Abbott Kaletra African AIDS Initiative Could Cost $800 Per Year
Executive Summary
Abbott expects the cost of the two HIV drugs it will offer through its distribution initiative in Africa, Kaletra and Norvir, to range between $800 and $1,000 per patient per year.
You may also be interested in...
Bristol HIV Price Cut Includes Pledge Not To Enforce Patent Rights In Africa
Bristol-Myers Squibb's HIV drug price cut for sub-Saharan African countries includes a pledge not to enforce patent rights for Videx (didanosine) and Zerit (stavudine).
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials